This year the AAL Forum AGEING WELL IN THE DIGITAL AGE: A growing community of change makers will be held on September 24-26 in Bilbao. It is pursuing the involvement of each attendee as a driver for change within their ecosystems. Seven members of the ‘Living well with Anne’ AAL-consortium will present a workshop on the 26th at 14.00 hours. In this workshop we will guide you through the seven steps and then invite you to take those steps for your own solution.
The percentage of old people in the population will rise, in part because of successful health policies. However, a longer life has problems of its own. Many ZonMw programmes are directed towards improving the health and welfare of elderly people. Our underlying conviction is that elderly people should be able to do things their own way, and as independently as possible, with the support of their social networks and – where necessary – professional help.
ZonMw works to achieve this through research, innovation, and attention for the dissemination and practical application of knowledge.
Learn more about co-creation and commercialisation of ICT solutions for older adults in the publication ‘The impact of AAL in the Netherlands’. The publication shows what the European Active & Assisted Living (AAL) programme has delivered for the Netherlands until now. Often in the words of those who directly involved. Their stories provide an inspiring glimpse into the future everyday lives of older adults.
The Joint Programming Initiative (JPI) More Years, Better Lives (MYBL) seeks to enhance coordination and collaboration between European and national research programmes related to demographic change in order to provide solutions for the upcoming challenges and to make use of the potential of societal change in Europe.
The Active and Assisted Living Joint Programme (AAL JP) is designed to foster the development of innovative technological/ICT-based products, services and systems to meet the needs of our ageing society and compensate for the expected staff shortages in the care sector. ZonMw is responsible for the implementation of AAL JP in the Netherlands.
In Europe, as well as globally, we face a number of societal challenges that no country or region can tackle alone. Addressing these so-called Grand Societal Challenges efficiently and effectively requires combined efforts and new ways of collaboration between countries. Today, there are 10 Joint Programming Initiatives (JPIs) with the aim to tackle Grand Societal Challenges. In a new brochure they explain the benefits of participating in a Joint Programming Initiative.
GloPID-R is pleased to welcome the Netherlands Organisation for Health Research and Development (ZonMw), represented by Suzanne Verver, into the network. GloPID-R is a unique international network of major research funding organizations. The network of 27 countries facilitates a rapid and effective research response to infectious disease outbreaks.
KNAW (Royal Netherlands Academy of Arts and Sciences), NWO (Netherlands Organisation for Scientific Research) and ZonMw (Netherlands Organisation for Health Research and Development) will sign the San Francisco Declaration on Research Assessment (DORA) on 18 April.
On April 1st 2019 the kick-off meeting of the European public-private partnership VALUE-Dx took place. This European-wide approach aims to generate evidence on the medical, economic, and public health value of diagnostics in tackling antimicrobial resistance (AMR). As a member of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), ZonMw participates in this consortium.
17 researchers who have recently received their PhDs can do their research at foreign research institutes thanks to a Rubicon grant from NWO. They will investigate, amongst other things, artificial intelligence for improved ultrasonography, Imaging muscle function in ALS patients, Printing living tissue through protective cell coating and new blood vessel formation.
While the pharmaceutical, medical technologies, chemical, cosmetics and food industries are increasingly seeking solutions to improve for example their prediction of clinical efficacy and/or risk and safety assessments without the use of animals, the solutions are still insufficient;
Societal demand for animal-free testing is increasing and there is a need for new innovations to improve human health, a stimulation of this research field is therefore needed;